This inventor holds 2 USPTO granted patents. Top assignees: Hoffmann-La Roche Inc., Roche Diagnostic Systems, Inc.. Active years: 1994-1998.
Company Filing History:
Years Active: 1994-1998
Title: The Innovations of Raymond Albert Hui
Introduction
Raymond Albert Hui is an accomplished inventor based in Lyndhurst, NJ (US). He has made significant contributions to the field of immunoassays, particularly in the development of reagents and compounds that enhance the detection of cannabinoids and other substances. With a total of 2 patents, Hui's work has implications in both medical and research settings.
Latest Patents
Hui's latest patents include "Reagents for a cannabinoid immunoassay" and "Compounds having improved fluorescence in fluorescence polarization." The first patent discloses novel benzpyran derivatives and their use in producing anti-cannabinoid antibodies. These antibodies serve as reagents in improved immunoassays for tetrahydrocannabinol metabolites found in biological fluid samples. The second patent focuses on compounds that possess enhanced properties in fluorescence polarization immunoassays, offering better intensity and a larger span.
Career Highlights
Throughout his career, Hui has worked with notable companies such as Hoffmann-La Roche Inc. and Roche Diagnostic Systems, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the field of immunoassays.
Collaborations
Hui has collaborated with several professionals in his field, including Kathryn Sarah Schwenzer and Steven Mark Rosen. These partnerships have likely enriched his research and development efforts, leading to the successful patents he holds today.
Conclusion
Raymond Albert Hui's contributions to the field of immunoassays demonstrate his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to improving detection methods, which can have a lasting impact on both research and clinical applications.